{"id":"W2472847770","doi":"10.1200/jco.2015.65.1901","title":"Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; Bayer HealthCare","keywords":"Regorafenib; Medicine; Internal medicine; Hazard ratio; Placebo; Ramucirumab; Clinical endpoint; Performance status; Gastroenterology; Adverse effect; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Confidence interval; Colorectal cancer; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003735072,0.001138581,0.001802924,0.0003552289,0.0003616759,0.0007923878,0.00081176,0.001313191,0.003981283],"category_scores_gemma":[0.001944188,0.0004648992,0.001725573,0.0005196339,0.0009708127,0.0007317767,0.0003690541,0.001769665,0.000497272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007639519,"about_ca_system_score_gemma":0.001595407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073761,"about_ca_topic_score_gemma":0.003734348,"domain_scores_codex":[0.9992976,0.0004549397,0.00003973968,0.00009159074,0.00005374697,0.00006228743],"domain_scores_gemma":[0.9991763,0.0001836125,0.0002982582,0.0000766089,0.00005700865,0.0002081773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9013793,0.009317844,0.00400925,0.002278405,0.003223488,0.00009027633,0.0001245063,0.0007628599,0.004835691,0.0001991708,0.002318992,0.07146022],"study_design_scores_gemma":[0.9259565,0.06628663,0.003600464,0.00009991487,0.001268574,0.00008807438,0.0000268729,0.0002849675,0.0005272249,0.00006896976,0.001779866,0.00001182557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9625394,0.02770736,0.000761489,0.001580338,0.0004169254,0.003294409,0.001037458,0.0001366595,0.002525822],"genre_scores_gemma":[0.975126,0.01214112,0.001974483,0.002207119,0.0005675358,0.004203967,0.001323531,0.00002029508,0.00243604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003981283,"threshold_uncertainty_score":0.01975316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1183170464801156,"score_gpt":0.494835759791865,"score_spread":0.3765187133117494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}